@ShahidNShah
As a global leader in blood component, therapeutic apheresis and cellular technologies, we believe in the potential of blood to do even more for patients than it does today. Working together with our customers, we can make safer, higher-quality transfusions available to more people. We can bring even more treatment options to patients through advanced blood therapies. And we can make the dream of new, cutting-edge blood and cell therapies the new standard of care. Our work has the potential to fundamentally improve health care.
Redefining Apheresis Excellence:
Boost productivity, collect higher-quality components, and improve the apheresis experience. The new Trima Accel 7 includes some exciting improvements to a …
Posted Laboratory Automation Digital Diagnostics
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm